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Abstract
With increasing healthcare-associated infections and antibiotic-resistant microorganisms there is a demand not
only for new antimicrobial compounds but also for antimicrobial materials. With the use of synthetic protein
biotechnology approaches and recombinant DNA technology, we can now create new tailor-made materials with
precise control over its sequence. Indeed, by combining antimicrobial activity of naturally occurring antimicrobial
peptides (AMPs) with recombinant protein-based polymers, such as elastin-like recombinamers (ELRs), it is
possible to create novel materials that can be explored for the development of advanced antimicrobial medical
devices. In the present work, we have functionalized an ELR with AMPs for the development of biopolymers with
antimicrobial activity. The antimicrobial ELRs were designed by cloning the DNA sequence coding for di erent
AMPs in frame with the N-terminus of an ELR consisting of 200 repetitions of the pentamer VPAVG (A200). The new
functionalized recombinant biopolymers were puri ed via a simpli ed non-chromatographic method, making use
of the thermoresponsive behaviour of A200. These were further processed into di erent materials namely,
particles by self-assembling,  bres by electrospinning and free-standing  lms by solvent casting. The produced
materials demonstrated to be highly e ective against di erent microorganisms including Gram-positive and
Gram-negative bacteria, yeasts and  lamentous fungi. Further, the antimicrobial performance showed to be time-
dependent and mediated by direct contact with cells, suggesting a mechanism of irreversible cell damage and
disruption. Moreover, the antimicrobial materials demonstrated to be non-cytotoxic to both normal human skin
 broblasts and human keratinocytes. Finally, we have developed an optimized ex vivo assay with pig skin for
testing the antimicrobial activity of  lm-type materials targeted for skin applications.
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